Fruit And Vegetables and OUtcomes After Removal of Impacted TEeth
Launched by UNIVERSITY OF BIRMINGHAM · Jun 16, 2010
Trial Information
Current as of May 13, 2025
Completed
Keywords
ClinConnect Summary
In general antioxidant status appears to influence wound healing in humans and in animal models of acute trauma, with low antioxidant concentrations and excessive oxidative stress being associated with impaired healing. Whilst antioxidant supplementation has been reported to improve plasma antioxidant status and wound healing in animal models of acute trauma, there is remarkably little data from human studies.
The use of Juice Plus+ has been reported to increase serum concentrations of important antioxidants and reduce serum markers of oxidative stress. However, to date there are no report...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patient requiring surgical removal of a single (unilateral) mandibular wisdom tooth
- • 2. Tooth requiring full mucoperiosteal flap to be raised for removal
- • 3. Bone removal necessary during procedure.
- Exclusion Criteria:
- • 1. Patients refusing to give written informed consent
- • 2. Clinically significant or unstable physical or mental disability rendering the participants incapable of complying with the study protocol as judged by the investigator
- • 3. Pregnant or breast-feeding women
- • 4. Patients taking long term anti-microbial or anti-inflammatory drugs
- • 5. Patients unable to swallow Juice Plus capsules
- • 6. Patients taking regular vitamin or mineral supplementation
- • 7. Patients requiring pre-operative antibiotics for surgery
- • 8. Patients requiring concomitant extractions or contralateral lower 3rd molar removal
- • 9. Allergic to any of the ingredients contained in supplements or placebo medication.
About University Of Birmingham
The University of Birmingham is a leading research institution in the UK, renowned for its commitment to advancing medical science and improving health outcomes through innovative clinical research. With a strong emphasis on collaboration, the university engages in multidisciplinary studies that leverage cutting-edge technology and expertise across various fields. Its dedicated clinical trial infrastructure supports rigorous investigation and the ethical conduct of research, ensuring that findings contribute meaningfully to the scientific community and public health. Through its initiatives, the University of Birmingham aims to translate research discoveries into tangible benefits for patients and healthcare systems alike.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, West Midlands, United Kingdom
Patients applied
Trial Officials
Thomas Dietrich, DMD, MD, MPH
Principal Investigator
University of Birmingham
Iain Chapple, BDS, PhD
Principal Investigator
Unversity of Birmingham
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials